Clinical Trials
5 trialsNCT00049400 2015-04-03
S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
SWOG Cancer Research Network
Phase 1 Completed
NCT00058019 2014-05-23
Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00052572 2013-06-24
Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
National Cancer Institute (NCI)
Phase 2 Completed
NCT00006221 2013-02-11
BMS-247550 in Treating Patients With Advanced Cancers
National Cancer Institute (NCI)
Phase 1 Completed
NCT00030108 2012-03-15
Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy
National Institutes of Health Clinical Center (CC)
Phase 1 Completed